我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
3
0 进行中
药物批准
56
批准总数
监管机构
监管机构数
成立时间
N/A
已完成
1
33.3%
暂停
终止
CANADA
Health Canada
53
PHILIPPINES
Philippines FDA
SFDA
Saudi Food and Drug Authority
2
- Mochida Pharmaceutical and Duchesnay Inc. have signed a licensing agreement to bring Bonjesta® to Japan, addressing nausea and vomiting of pregnancy affecting over half of Japanese pregnant women. - The partnership responds to Japan's Ministry of Health call to address "drug loss," where treatments approved in the US and Europe remain unavailable in Japan. - Bonjesta®, containing doxylamine succinate and pyridoxine hydrochloride, is already approved in 43 countries worldwide with potential Japanese launch anticipated by 2030.
